The DMA said the findings were strong enough that there should be an investigation into whether or not NAION should be listed as a possible adverse event when taking Ozempic
Inicialmente desenvolvidos para o tratamento do diabetes tipo 2, esses medicamentos passaram a ganhar destaque tambm no tratamento da obesidade e de outras condies metablicas
And that was more our motivation to actually continue to invest in obesity
Insurance appeals are commonand often successfulwhen supported with proper medical documentation
However, emerging data and mechanistic plausibility suggest that certain populations may be at higher risk of suboptimal intake or depletion, particularly with prolonged therapy, rapid weight loss, restricted dietary variety or pre-existing marginal nutrient status
Indeed, the rate of major birth defects often lies between 5% and 10% among women with pregestational diabetes 25 3133 but depends on the maternal blood sugar level